Florbetapir PET PC2+WM SUVR

Biomarker

2 findings

Associations

2

Neuritic plaque positivity

upin humans1

1 study
  1. Florbetapir PET PC2+WM SUVR predicts neuritic plaque positivity in humans (AUC 0.82 (95% CI 0.76–0.89)).

    “0.82 (95% CI 0.76–0.89) for neuritic plaque, with an optimal cutoff of 0.77 for both outcomes.”

    Humansbrainn = 165

    Amyloid quantification in the oldest-old: selecting regions for optimizing correspondence between postmortem pathology and amyloid PET

    Acta neuropathologica communications1 Dec 2025

More on Neuritic plaque positivity

Amyloid-beta positivity

upin humans1

1 study
  1. Florbetapir PET PC2+WM SUVR predicts amyloid-beta positivity in humans (AUC 0.84 (95% CI 0.78–0.90)).

    “The best performing SUVR was the PC2+WM, yielding an area under the curve (AUC) of 0.84 (95% CI 0.78–0.90) for amyloid beta”

    Humansbrainn = 165

    Amyloid quantification in the oldest-old: selecting regions for optimizing correspondence between postmortem pathology and amyloid PET

    Acta neuropathologica communications1 Dec 2025

More on Amyloid-beta positivity